Name | Value |
---|---|
Revenues | 382.4M |
Cost of Revenue | 164.1M |
Gross Profit | 218.3M |
Operating Expense | 191.8M |
Operating I/L | 26.6M |
Other Income/Expense | -8.0M |
Interest Income | 4.6M |
Pretax | 18.6M |
Income Tax Expense | -0.9M |
Net Income/Loss | 19.5M |
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for neurosurgery, extremity reconstruction, and general surgery. Its products include neurosurgery and neuro critical care equipment, surgical headlamps, asset management software, regenerative technology products for wound treatment, and surgical tissue repair products for hernia repair, peripheral nerve repair, and tendon repair. The company sells its products directly to hospitals, surgery centers, dental, podiatry, and veterinary offices, as well as through various distribution channels in the United States, Europe, Asia Pacific, and internationally.